These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6814971)

  • 1. [Use of a new steroid (Org OD 14) in the climacteric syndrome].
    Cittadini J; Ben J; Badano AR; Denari HJ; Quiroga S; Marcus AE; Schlaen I; Figueroa Casas PR
    Reproduccion; 1982; 6(2):69-79. PubMed ID: 6814971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-controlled cross-over study of effects of Org OD 14 in menopausal women.
    Kicovic PM; Cortés-Prieto J; Luisi M; Milojevic S; Franchi F
    Reproduccion; 1982; 6(2):81-91. PubMed ID: 6754512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New steroid for the climacteric syndrome.
    Kicovic PM
    Minerva Endocrinol; 1989; 14(1):63-7. PubMed ID: 2659954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D; Posea C; Ceausu I; Rusu M
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A preliminary report on the treatment of climacteric symptoms with Org OD14].
    Wu YY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Sep; 28(9):539-41, 569-70. PubMed ID: 8313747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of climacteric complaints with Org OD 14: a comparative study with oestradiol valerate and placebo.
    Crona N; Samsioe G; Lindberg UB; Silfverstolpe G
    Maturitas; 1988 Mar; 9(4):303-8. PubMed ID: 3288845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Org OD 14 for the treatment of climacteric complaints.
    De Aloysio D; Fabiani AG; Mauloni M; Bottiglioni F
    Maturitas; 1987; Suppl 1():49-65. PubMed ID: 3306291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the synthetic steroid Org OD14 on fibrinolysis and blood lipids in postmenopausal women.
    Walker ID; Davidson JF; Richards A; Yates R; McEwan HP
    Thromb Haemost; 1985 Jun; 53(3):303-5. PubMed ID: 3901389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term placebo-controlled efficacy and safety study of Org OD 14 in climacteric women.
    Benedek-Jaszmann LJ
    Maturitas; 1987; Suppl 1():25-33. PubMed ID: 3306289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of tibolone and estrogen replacement therapy on echocardiographic basic cardiac functions in post-menopausal women: a randomized placebo controlled study.
    Taskin O; Muderrisoglu H; Akar M; Simsek M; Mendilcioglu I; Kursun S
    Maturitas; 2004 Aug; 48(4):354-9. PubMed ID: 15283927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile of Org OD 14.
    Tax L; Goorissen EM; Kicovic PM
    Maturitas; 1987; Suppl 1():3-13. PubMed ID: 3306290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Org OD 14 in the treatment of climacteric complaints.
    Trévoux R; Dieulangard P; Blum A
    Maturitas; 1983 Aug; 5(2):89-96. PubMed ID: 6633272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
    Landgren MB; Helmond FA; Engelen S
    Maturitas; 2005 Mar; 50(3):222-30. PubMed ID: 15734603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.
    Lindsay R; Hart DM; Kraszewski A
    Br Med J; 1980 May; 280(6225):1207-9. PubMed ID: 6992927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation and fibrinolysis in post-menopausal women treated with Org OD 14.
    Cortes-Prieto J
    Maturitas; 1987; Suppl 1():67-72. PubMed ID: 3306292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
    Limpaphayom KK; Bunyavejchevin S
    J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind cross-over study with Org OD 14 and placebo in postmenopausal patients.
    Nevinny-Stickel J
    Arch Gynecol; 1983; 234(1):27-31. PubMed ID: 6660926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of Org OD 14--a new steroidal therapy for climacteric symptoms.
    Hardiman P; Nihoyannopoulos P; Kicovic P; Ginsburg J
    Maturitas; 1991 Sep; 13(3):235-42. PubMed ID: 1943831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H; Al-Azzawi F;
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.